Arkolith/Insider Trading/CLVS/Form 4

Rolfe Lindsey

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Sep 6, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 2, 2022Sell(S)3K$1.20$3K110K
Sep 1, 2022Option exercise(M)5K——112K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2022Option exercise(M)5K—$051K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-030421) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML